TY - JOUR
T1 - Optimizing pain treatment interventions (OPTI)
T2 - A pilot randomized controlled trial of collaborative care to improve chronic pain management and opioid safety—Rationale, methods, and lessons learned
AU - Seal, Karen H.
AU - Borsari, Brian
AU - Tighe, Jennifer
AU - Cohen, Beth E.
AU - Delucchi, Kevin
AU - Morasco, Benjamin J.
AU - Li, Yongmei
AU - Sachs, Emily
AU - Abadjian, Linda
AU - Watson, Erin C.
AU - Manuel, Jennifer K.
AU - Vella, Lea
AU - Trafton, Jodie
AU - Midboe, Amanda
N1 - Funding Information:
This work was supported by the National Center for Complimentary and Integrative Health under Award No. 1 R34 AT008319-01 . None of the authors have any conflicts of interest to disclose.
Funding Information:
This three-year study was funded under a National Institutes of Health (R34) award, a mechanism which allows for the iterative development and pilot testing of a study intervention protocol ( https://grants.nih.gov/grants/funding/r34.htm ). Intervention development was conducted in three phases.
Publisher Copyright:
© 2018
PY - 2019/2
Y1 - 2019/2
N2 - Veterans seeking care in VA medical facilities have high rates of chronic pain, which often co-occur with mental health and substance use disorders, including prescription opioid misuse. The overall goal of the Optimizing Pain Treatment Interventions (OPTI) study was to pilot a 12-week Collaborative Care intervention to improve opioid safety, chronic pain disability, and use of non-pharmacological pain management strategies in veterans in VA primary care. Between November 2014 and January 2017, 100 veteran patients with chronic pain and high-risk prescription opioid use (e.g., high-dose therapy, early refills, etc.) were enrolled and completed an initial one-hour study visit with a primary care provider (PCP) within 4 weeks of enrollment. Study PCPs were guided by a web-based opioid management decision support program and templated notes in the VA electronic medical record. After assessment and education, study PCPs used Shared Decision-Making to formulate a Pain Care Plan aligned with a participant's personal values and goals. After the initial visit, patients randomized to Collaborative Care received one Motivational Interviewing (MI) session with a Care Manager followed by 3 Care Manager-delivered brief telephone MI sessions at 6, 8, and 12 weeks to reinforce Pain Care Plans; patients randomized to an Attention Control condition met with a Care Manager briefly, followed by 3 brief scripted telephone psychoeducation sessions at 6, 8, and 12 weeks. Masked evaluators assessed outcomes at baseline, end of intervention (12 weeks), and after eight weeks of no contact (20 weeks). We present study rationale, detailed methods, preliminary results and lessons learned.
AB - Veterans seeking care in VA medical facilities have high rates of chronic pain, which often co-occur with mental health and substance use disorders, including prescription opioid misuse. The overall goal of the Optimizing Pain Treatment Interventions (OPTI) study was to pilot a 12-week Collaborative Care intervention to improve opioid safety, chronic pain disability, and use of non-pharmacological pain management strategies in veterans in VA primary care. Between November 2014 and January 2017, 100 veteran patients with chronic pain and high-risk prescription opioid use (e.g., high-dose therapy, early refills, etc.) were enrolled and completed an initial one-hour study visit with a primary care provider (PCP) within 4 weeks of enrollment. Study PCPs were guided by a web-based opioid management decision support program and templated notes in the VA electronic medical record. After assessment and education, study PCPs used Shared Decision-Making to formulate a Pain Care Plan aligned with a participant's personal values and goals. After the initial visit, patients randomized to Collaborative Care received one Motivational Interviewing (MI) session with a Care Manager followed by 3 Care Manager-delivered brief telephone MI sessions at 6, 8, and 12 weeks to reinforce Pain Care Plans; patients randomized to an Attention Control condition met with a Care Manager briefly, followed by 3 brief scripted telephone psychoeducation sessions at 6, 8, and 12 weeks. Masked evaluators assessed outcomes at baseline, end of intervention (12 weeks), and after eight weeks of no contact (20 weeks). We present study rationale, detailed methods, preliminary results and lessons learned.
UR - http://www.scopus.com/inward/record.url?scp=85059114686&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85059114686&partnerID=8YFLogxK
U2 - 10.1016/j.cct.2018.12.006
DO - 10.1016/j.cct.2018.12.006
M3 - Article
C2 - 30572163
AN - SCOPUS:85059114686
SN - 1551-7144
VL - 77
SP - 76
EP - 85
JO - Contemporary Clinical Trials
JF - Contemporary Clinical Trials
ER -